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In Brief
Transcription termination of noncoding
RNAs by the Nrd1-Nab3-Sen1 (NNS)
complex is affected by Sen1 protein
levels. Controlled Sen1 degradation
during the G1 phase of the cell cycle
reduces NNS termination efficiency. In
contrast, increased Sen1 levels lead to
overactive noncoding RNA termination
and reduced cell viability.
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Many non-coding transcripts (ncRNA) generated by
RNA polymerase II in S. cerevisiae are terminated
by the Nrd1-Nab3-Sen1 complex. However, Sen1
helicase levels are surprisingly low compared with
Nrd1 and Nab3, raising questions regarding how
ncRNA can be terminated in an efficient and timely
manner. We show that Sen1 levels increase during
the S and G2 phases of the cell cycle, leading to
increased termination activity of NNS. Overexpres-
sion of Sen1 or failure to modulate its abundance by
ubiquitin-proteasome-mediated degradation greatly
decreases cell fitness. Sen1 toxicity is suppressed
by mutations in other termination factors, and NET-
seq analysis shows that its overexpression leads to
a decrease in ncRNA production and altered mRNA
termination. We conclude that Sen1 levels are care-
fully regulated to prevent aberrant termination. We
suggest that ncRNA levels and coding gene tran-
scription termination are modulated by Sen1 to fulfill
critical cell cycle-specific functions.
INTRODUCTION
Genome-wide studies have unearthed a vast array of non-
coding RNAs (ncRNAs) and aberrant transcripts that are mostly
unstable and degraded in proximity to their transcription site
(Jacquier, 2009; Wyers et al., 2005). Many of these transcripts
arise through opportunistic transcription initiation events from
nucleosome-depleted regions (NDRs) or result from failed 30
end processing of coding transcripts (Pelechano et al., 2013;
Rondo´n et al., 2009).
In S. cerevisiae, a large fraction of ncRNA is terminated by
a specialized mechanism employing Nrd1-Nab3-Sen1 (NNS),
which is distinct from the polyadenylation-coupled termination
mechanism used for mRNA (Steinmetz et al., 2001). At ncRNAs,312 Molecular Cell 70, 312–326, April 19, 2018 ª 2018 The Authors. P
This is an open access article under the CC BY license (http://creativeNrd1-Nab3 heterodimers associate with the RNA polymerase II
(Pol II) C-terminal domain (CTD), positioned to recognize short
RNA sequence elements (GUA(A/G) for Nrd1 and UCUU(G) for
Nab3) (Carroll et al., 2004, 2007; Porrua et al., 2012) and to recruit
the superfamily I helicase Sen1. Sen1 consequently disengages
Pol II from the DNA template (Martin-Tumasz and Brow, 2015;
Porrua and Libri, 2013). By remaining bound to RNA, Nrd1 can
recruit the exosome to degrade many NNS terminated tran-
scripts (Vana´cova´ et al., 2005; Vasiljeva and Buratowski, 2006;
Wyers et al., 2005). Overall, RNA degradation mutants have
allowed detection of at least 6,000 ncRNAs in baker’s yeast
(Mischo and Proudfoot, 2013), but functions have only been
assigned to a fraction of these.
The 30 end processing and termination of mRNA in
S. cerevisiae requires the multi-protein cleavage and polyadeny-
lation factor (CPF), comprised of three sub-complexes. Cleav-
age factors IA and IB (CFIA/B) recognize the RNA sequences
specifying polyadenylation, leading to recruitment of CPF, which
cleaves the pre-mRNA at the poly(A) site (PAS) and initiates
polyadenylation. Cleavage generates a new uncapped 50 RNA
end onto which the exonuclease Rat1 loads to degrade the
downstream transcript and release elongating Pol II (Fong
et al., 2015; Kim et al., 2004; West et al., 2004).
Both termination pathways are connected through APT (asso-
ciated with Pta1), a sub-complex associated with about half of
the cellular CPF pool. APT is thought to modulate CPF activity
and is required for the termination of many NNS substrates (re-
viewed in Mischo and Proudfoot, 2013). In addition to ncRNA
termination, NNS also regulates the expression of some 42–305
mRNA genes by attenuation (Arigo et al., 2006; Creamer et al.,
2011; Jamonnaket al., 2011;Schulz et al., 2013). Finally, onhighly
transcribed mRNA genes, NNS acts as a ‘‘failsafe’’ termination
pathway for Pol II molecules that read through a PAS (Rondo´n
et al., 2009;Webb et al., 2014). Overall, NNS restricts inadvertent
transcription and controls gene expression through termination.
The cellular abundance of Nrd1 and Nab3 is estimated some-
what above that of RNA Pol II (Nrd1, 550–20,000; Nab3, 2,000–
6,000; Pol II, 600–1,000) (Chong et al., 2015; Ghaemmaghami
et al., 2003; Kulak et al., 2014; Newman et al., 2006). In contrast,
the levels of Sen1, the enzymatic component of NNS, are wellublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Sen1 Protein Levels Fluctuate throughout the Cell Cycle
(A) Cells were aF-arrested and released into the cell cycle for the indicated time (see FACS analysis, right). Levels of C-terminally tagged Sen1-Myc (9E11), Sic1,
and Pgk1 were analyzed by immunoblotting (left).
(B) RNA analysis of SEN1 and sCR1. RNA was prepared from cells grown as in (A) (see FACS analysis, right), and 10 mg was separated on a 1% agarose gel for
RNA blotting (left).
(C) Sen1 expression in drug-arrested cells. Cells grown in yeast extract, peptone, and dextrose (YPD) were arrested in G1 (5 mg/mL aF), S phase (200 mM
hydroxyurea [HU]), or prometaphase (PM, 15 mg/mL nocodazole, see FACS analysis, right). Extract equivalent to 0.53 107 cells (Nrd1) or 23 107 cells (TBP, Sic1,
Nab3, and Sen1 [antibody against the N terminus]) was analyzed by immunoblotting (left).
(D) Sen1 expression in elutriated cells. Cells grown in YPD were separated by elutriating centrifugation and analyzed by FACS. Extracts prepared from fractions
with G1, S, and G2 DNA content were analyzed by immunoblotting for Sen1-Myc (9E11), TBP, and Sic1. Quantification of three independent elutriations
normalized to G1 levels with SEM is shown below.
(E) RNA blot analysis of SNR13 and SNR13::TRS31 RNA. Wild-type, pcf11-9, ssu72-2, and sen1-1 cells grown in YPD at a permissive temperature (25C),
were arrested with aF or nocodazole and shifted to a non-permissive temperature (37C) for 30 min. nrd1-102 cells were grown in YPD at 30C before arrest
(legend continued on next page)
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below Nrd1-Nab3 (64–500). This low copy number may suggest
that Sen1 shuttles between various Nrd1-Nab3 heterodimers
already bound to nascent RNA, effectively awaiting Sen1 to
complete transcription termination. In addition, Sen1 may have
functions outside of NNS because SEN1 mutation results in
aberrant nucleolar organization, genome instability, and replica-
tion defects (Alzu et al., 2012; Mischo et al., 2011; Ursic et al.,
1995, 2004).
Given such widespread cellular demand for Sen1 action, it
appears surprising that its levels are kept low by proteasomal
degradation (DeMarini et al., 1995). We therefore speculated
that Sen1 levels might be adjusted to cellular demand, which
might increase at certain points during the cell cycle; for
example, when transcription encounters replication in S phase.
To test this hypothesis, we monitored Sen1 abundance
throughout the cell cycle and found that it increases in the
S and G2 phases. We show that the ubiquitin-proteasome
system degrades Sen1 preferentially during G1.
Cell cycle-specific E3 ubiquitin ligases of the ubiquitin-pro-
teasome system ensure directional flow through the cell cycle
(Finley et al., 2012; Sivakumar and Gorbsky, 2015) by marking
ubiquitin-proteasome system substrates for timely degrada-
tion. During metaphase, the multi-subunit ubiquitin ligase
anaphase-promoting complex (APC) binds its adaptor Cdc20
to degrade Pds1/Securin. This triggers anaphase and APC
association with its alternative adaptor Cdh1. APCCdh1 regu-
lates entry into S phase by keeping S phase cyclins low.
Although APC can have substrates with functions outside of
cell cycle control (Menzel et al., 2014; Ostapenko et al.,
2012), G1-specific degradation of a general transcription termi-
nation factor required in all phases of the cell cycle is unex-
pected. We find that, when Sen1 degradation is perturbed,
ncRNA abundance and mRNA termination efficiency are sub-
stantially affected, and cell death is provoked. This argues
that control of Sen1 levels and RNA termination throughout
the cell cycle are critical.
RESULTS
Sen1 Protein Levels and Activity Fluctuate throughout
the Cell Cycle
To monitor Sen1 abundance over the cell cycle, cells expressing
C-terminally Myc-tagged Sen1 were synchronized by alpha-fac-
tor (aF) arrest in late G1. After release, samples were taken every
15 min over a 2-hr time course and processed for immunoblot-
ting and fluorescence-activated cell sorting (FACS) analysis (Fig-
ure 1A). In whole-cell extracts, Sen1 levels are reduced in G1 and
increase toward S/G2, a pattern opposite to the G1-expressed
Cdc28 inhibitor Sic1. This 10-fold difference in protein levels
relative to aF arrest (Figure S1A) is primarily post-transcriptional
because SEN1 mRNA increases less than 2-fold in G2
(Figure 1B).with aF or nocodazole. 15 mg RNA was separated on a 1% agarose gel and ana
the SNR13::TRS31 termination readthrough transcript (schematized above). T
normalized to the G1 value (y axis, SEM). Statistical significance of the differe
**p < 0.01.
314 Molecular Cell 70, 312–326, April 19, 2018We excluded the possibility that Sen1 reduction in G1 reflects
C-terminal partial proteolysis by monitoring Sen1 levels with an
antibody raised against its N terminus (Figure 1C). In drug-
arrested cells, Sen1 abundance decreases in G1 (aF) and in-
creases in prometaphase (PM) after nocodazole arrest. The G1
depletion is specific to Sen1 because neither Nrd1 nor Nab3
levels fluctuate markedly throughout the cell cycle. Again, the
levels of SEN1mRNA isolated from arrested cells remain similar
(Figure S1B).
Finally, to discount that aF treatment artifactually causes Sen1
reduction, SEN1-Myc-tagged cells were elutriated to separate
cells with G1, S, or G2 phase DNA content (Figure 1D). Although
constant levels of SEN1 mRNA are seen in all stages (Fig-
ure S1C), Sen1 protein levels are reduced 3-fold in G1 cells.
If Sen1 is limiting within NNS, thenwe speculated that NNS ac-
tivitymight be higher duringG2whenSen1 levels rise. To test this
hypothesis, wemonitored termination ofSNR13, whose termina-
tion depends onNNS, APT, and theCF1A subunit Pcf11 (Grzech-
nik et al., 2015; Nedea et al., 2003; Steinmetz and Brow, 2003;
Steinmetz et al., 2001). When wild-type termination fails, the
SNR13 transcript is extended to the PAS of the downstream
TRS31 gene, forming a stable bi-cistronic RNA that allows quan-
tification of transcription readthrough. Comparing SNR13 tran-
scripts in G1- and PM-arrested cells (Figure 1E), we observed
no readthrough in a wild-type strain but saw marked differences
in the sensitized background of temperature-sensitive mutations
in Pcf11 or theAPT component Ssu72. Both ssu72-2 andpcf11-9
strains (at permissive and non-permissive temperatures) show
significantly less readthrough during mitotic arrest, when Sen1
protein levels are higher. A similar effect is seen in an nrd1-102
mutant. In contrast, when Sen1 itself is compromised by the
sen1-1 mutation, termination is equally defective during G1 and
PM, suggesting that limiting Sen1 in G1 causes reduced termina-
tion efficiency at SNR13.
In summary, we conclude that Sen1 protein levels vary
throughout the cell cycle and that this variation affects transcrip-
tion termination efficiency at SNR13.
Sen1 Is Degraded by the Ubiquitin-Proteasome System
To determine whether Sen1 protein levels change through
differential protein degradation, we performed a translation
shutoff experiment. A plasmid-encoded, C-terminally Myc-
tagged SEN1 under control of the galactose-inducible GAL1
promoter (pGSen1Myc) was expressed for 1 hr in G1- or PM-
arrested cells prior to translation inhibition with cycloheximide
(CHX) (Figure S2A). In G1-arrested cells, most Sen1 is lost
6 min after translational shutoff (Figure 2A). In contrast, higher
levels of Sen1 accumulate in mitosis-arrested cells, and these
remain high when CHX is added. This suggests that Sen1 is
unstable during G1.
The majority of regulated protein turnover in eukaryotic cells
is mediated by the ubiquitin-proteasome system (reviewed inlyzed by RNA blotting (left) against SNR13 to detect the mature snoRNA and
he readthrough-to-snoRNA ratio for three to four biological replicates was
nce between G1 and PM was calculated using Students’ t test. *p < 0.05,
A B
C D
Figure 2. Sen1 Is Ubiquitylated and Degraded by the Proteasome
(A) Sen1 stability differs in G1- and PM-arrested cells. pGSen1Myc-transformed cells (bar1D) were grown in raffinose-containing medium and arrested with
0.15 mg/mL aF or 15 mg/mL nocodazole. Sen1-Myc expression was induced by addition of 2% galactose for 15 min, followed by transcription repression
by addition of 2% glucose and translation inhibition after 1 hr by addition of 1 mg/mL CHX. Whole-cell extracts from the indicated time points were assayed for
Sen1-Myc levels; quantification (average of n = 3 and SEM) is graphed below. See Figure S2A for FACS analysis.
(B) Sen1 degradation in G1 depends on proteasome function. Sen1-Myc cells (bar1D, pdr5D) were aF-arrested and treated with 1 mg/mL CHX. The culture was
split in half and treated with DMSO (lanes 2–6) or 140 mMMG-132 and 20 mM MG-262 (lanes 7–10). See Figure S2B for FACS analysis. Graph: average of n = 3
with SEM.
(C) Sen1 is stabilized in the APCmutant cdc27-A. pGSen1Myc-transformed cdc27-A and CDC27 cells were aF-arrested in raffinose at 23C and shifted to 37C,
and Sen1-Myc expression was induced with 2% galactose for 15 min, after which 2% glucose was added. CHX was added after 30 min, and residual Sen1 was
analyzed as before. Graph: average of n = 3 CDC27 and n = 4 cdc27-A with SEM. See Figure S2D for FACS analysis.
(D) Sen1 is stabilized in metaphase-arrested cells. A galactose-inducible, non-cleavable Pds1 (Pds1Db1D) was integrated into Sen1-Myc cells. After aF arrest in
raffinose, Pds1Db1D cells were released into galactose-containing medium, and CHX was added after 80 min., when most cells were arrested in metaphase
(lanes 8–14). This was compared with Sen1-Myc wild-type cells, aF-arrested, and maintained in galactose for 80 min (lanes 1–7). Quantification (average and
SEM, n = 4–5) is shown at the bottom. See Figure S2E for FACS analysis.
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Finley et al., 2012). To test whether the proteasome is respon-
sible for Sen1 degradation in G1, we measured the half-life of
endogenous Sen1-Myc in the presence of the proteasome inhib-
itors MG-132 and MG-262 (Gaczynska and Osmulski, 2005; Fig-
ures 2B and S2B). We note that, in aF-arrested cells, endoge-
nous Sen1 is degraded with somewhat slower kinetics than the
plasmid-encoded Sen1 (compare Figure 2A with Figure 2B).
However, upon proteasome inhibition, polyubiquitin accumu-
lates, and Sen1 degradation is clearly prevented.
Sen1 Degradation Is Initiated through APC-Mediated
Ubiquitylation
G1-specific degradation of proteins is often initiated through
APCCdh1. In the temperature-sensitive APC subunit mutant
cdc27-A, Sen1 expressed from pGSen1Myc at non-permissive
temperatures is noticeably stabilized after CHX treatment,
arguing that Sen1 is an APC substrate (Figures 2C and S2D).
Similarly, protein steady-state abundance increases modestly
in the cdc16-123 temperature-sensitive mutant of APC (Fig-
ure S2C). In early mitosis, APC recognizes substrates through
the alternative adaptor Cdc20, and this activity initiates chromo-
some segregation through degradation of Pds1. Because APC is
inhibited by nocodazole activation of the spindle attachment
checkpoint (SAC; Sivakumar and Gorbsky, 2015), we wished
to exclude that Sen1 stabilization by nocodazole was caused
by APC inhibition. To this end, we arrested cells in mitosis by ar-
tificially stabilizing Pds1 to prevent chromosome segregation
(Figures 2D and S2E). In the presence of active APC in mostly
metaphase-arrested cells, endogenous Sen1 remains stabilized,
albeit to a lesser extent than seen in APC inhibited cells (Fig-
ure 2A). We conclude that APC is responsible for Sen1 degrada-
tion during G1 and contributes to its modest turnover in early
mitosis.
Levels of Sen1 Protein Affect Viability
The APC adaptors Cdc20 and Cdh1 recognize distinct amino
acid (aa) motifs in their respective substrates, which aids tempo-
ral separation of substrate degradation. However, neither the
destruction box (D-box) sequence (RXXLXXXXN, Cdc20) nor
the lysine, glutamic acid, asparagine (KEN)-box (RxxxxxKEN,
Cdh1) are unambiguously defined, and many substrates carry
shortened, combined, or even alternative motifs (Sivakumar
and Gorbsky, 2015). We reasoned that abrogating APC-medi-
ated Sen1 turnover should allow us to study the biological signif-
icance of Sen1 degradation and therefore examined its aa
sequence for potential minimal APC degradation motifs (RxxL
and RxxxxxKEN). Although we found no APC recognition motifs
within aa 552–659, deletion of which had earlier been shown to
increase Sen1 levels (DeMarini et al., 1995), we did find a cluster
of two potential D-boxes and a KEN box within aa 480–493 (Fig-
ures 3A and S3A). Deletion of 40 aa, including these boxes (aa
459–498), led to marked stabilization of the protein expressed
from pGSen1Myc-459-498D in G1 (Figures 3B and S3B). How-
ever, alanine substitution of KENwithin this box failed to stabilize
the protein. Unfortunately, other alanine substitutions lead to
protein destabilization, making it difficult to further dissect the
aa requirement for Sen1 degradation within this region and test
whether D-boxes contributed to Sen1 destabilization. Conse-316 Molecular Cell 70, 312–326, April 19, 2018quently, our analysis supports the view that Sen1 degradation
depends on aa that resemble APC motifs but does not allow
us to conclude unequivocally whether Sen1 acts solely as an
APCCdh1 substrate.
To study the phenotype of slowed Sen1 turnover, we sought
to replace genomic Sen1 with the Sen1-459-498D allele in a
plasmid shuffle assay. Because SEN1 is essential, sen1D cells
die when an empty vector is shuffled but survive when the shuffle
vector carries wild-type SEN1 (Figure 3C). Surprisingly, cells are
still extremely sick when expressing only Sen1-459-498D pro-
tein, suggesting a correlation between Sen1 protein stabilization
in G1 and reduced cell fitness. Alanine substitution of the
potential degradation motifs evoked mild growth retardation,
indicating that these APC-like motifs may contribute to the regu-
lation of Sen1 (Figure S3C).
We verified that the various mutant alleles retained Sen1 func-
tion by testing their ability to complement the temperature sensi-
tivity of the sen1-1mutant (Figure S3D) and found that the Sen1-
459-498D allele was still functional as a termination factor,
capable of suppressing the sen1-1 transcription termination
defect in various genomic loci (Figures 3D and S3E).
Altogether, our data suggest that Sen1 is a substrate for ubiq-
uitin-proteasome system-mediated degradation, preferentially
during G1, and that interference with this regulation reduces
cell viability.
Toxicity of Sen1 Overexpression Is Related to Its
Termination Function
Given the reduced viability of sen1-459-498D cells, we sought
a more amenable approach for studying the phenotype
of increased Sen1 concentration in G1. Performing CHX
chases in aF-arrested cells, we previously observed that pro-
longed expression from the multi-copy galactose-inducible
pGSen1Myc led to Sen1 stabilization, perhaps by overwhelming
the proteasome. To observe the long-term consequences of
persistent Sen1 expression, we compared growth when expres-
sion from pGSen1Myc was induced or repressed. Although cells
grew on repressive glucose, they were unable to grow on galac-
tose medium (Figure 4A). Even in sen1-1 cells, which die when
the mutant Sen1 is destabilized at non-permissive temperatures
(see Figure 4A, bottom, 37C), expressing pGSen1Myc on
galactose is toxic. In contrast, on glucose, where the pGAL1
on pGSen1Myc is repressed, the low ‘‘leaky’’ expression level
of wild-type Sen1 complements the sen1-1 temperature sensi-
tivity. Importantly, both low- and high-level expression can
suppress the sen1-1 termination defect at SNR13 and SNR33
(Figures 4B and S4A), suggesting that minute amounts of Sen1
are sufficient to provide a sen1-1 strain with adequate Sen1 func-
tion but also that toxicity is not caused by a dominant-negative
effect of plasmid-expressed Sen1. Overall, these results suggest
that there is a window of optimal Sen1 concentration range,
outside of which cells die. Taking our half-life measurements
into account, we predict that sensitivity to increased Sen1 levels
mainly arises during the G1 phase of the cell cycle.
In an attempt to understand the observed toxicity of Sen1
expression, we considered two different but not mutually exclu-
sive models. According to the sequestration model (Figure 4Ci),
excess Sen1 titrates some interaction partner, resulting in the
AB C
D
Figure 3. A 40-aa Region within Sen1 Contributes to Its Instability in G1
(A) Schematic model of Sen1 domain organization. LeuZipper, a putative leucine zipper; NLS, nuclear localization sequence; Glc7, Glc7 binding motif.
(B) Deletion of aa 459–498 leads to Sen1 stabilization. 1 mg/mL CHX was added to aF-arrested wild-type cells (bar1D) transformed with pGSen1Myc variants
Sen1, Sen-459-498D, or Sen1-KEN-A as described in Figure 2A. The 60-min time points in the center and at the right are from a separate gel. Bottom graph:
n = 4–5, SEM. The asterisk denotes a Myc-responsive band possibly stemming from an internal promoter within Sen1, whose degradation is unchanged.
(C) RNA blot analysis (1%agarose) of 15 mgRNA isolated fromSEN1 or sen1-1 cells transformedwith vector, pGSen1Myc (Sen1), or Sen1-458-498D and induced
with galactose for 3 hr at a permissive temperature prior to a 30-min shift to a non-permissive temperature. RNA blots were probed against SNR13 orNRD1 (top).
Bottom: quantification normalized to sen1-1 vector readthrough (n = 3, SEM).
(D) Plasmid shuffle assay to test for the ability of query constructs to support viability. A centromericURA3 plasmid carrying SEN1 (pRS416 ± 700Sen1) maintains
the viability of a sen1D strain. Transformation with a query plasmid (vector, Sen1, Sen1-459-498D, or Sen1-D1-KEN-D2-A) and selection against the URA3
plasmid (with 5-fluorouracil [5-FOA]) leaves the query plasmid to complement the loss of SEN1. Five-fold serial dilutions. Selection medium: W, tryptophan;
L, leucine; U, uracil.partner’s insufficient activity. Alternatively, increased Sen1 activ-
ity (particularly during G1) could impair proper cellular func-
tion. For example, excessive termination might disrupt gene
expression (Figure 4Cii). To test for the sequestration model,
pGSen1Myc was expressed in genetic backgrounds that would
abolish interaction with potential interaction partners (Fig-
ure S4B). Deletion of RNT1 or RAD2, two non-essential Sen1
interaction partners, did not alleviate the toxicity of Sen1 expres-
sion (Ursic et al., 2004), nor did deletion of SRS2, which is
synthetic lethal with sen1-1 (Mischo et al., 2011). Similarly, point
mutations in Sen1 residues that abrogate interaction with the
essential proteins Rpb1 (R302W; Chinchilla et al., 2012) or
Glc7 (F2003A; Nedea et al., 2008) remained toxic when ex-
pressed from galactose-inducible plasmids (Figure S4C).To test the ‘‘excess activity model,’’ we reasoned that if higher
cellular Sen1 levels caused excessive and cytotoxic transcrip-
tion termination, then such overactivity might be offset, and
therefore tolerated, in transcription termination mutants (Fig-
ure 4Cii). Accordingly, a collection of mutant strains (either
deletion of non-essential genes or temperature-sensitive point
mutants for essential genes) was challenged with pGSen1Myc
(Figures 4D and 4E and S4D–S4G).
Three different outcomes were observed for the tested collec-
tion of mutant strains. First, as observed for sen1-1 (Figure 4A),
leakyGAL1 promoter expression of Sen1 on glucose suppresses
the temperature sensitivity of the NNS and CFI mutants nab3-11,
pcf11-9, and pcf11-13 (Figures S4D and S4E), which specifically
disrupt NNS termination (Kim et al., 2006; Steinmetz et al., 2001).Molecular Cell 70, 312–326, April 19, 2018 317
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Figure 4. Sen1 High Copy Expression Is Toxic
(A) Sen1 expression from the multi-copy pGSen1Myc plasmid in SEN1 and sen1-1 cells. 5-fold serial dilutions were grown on selective medium with either
glucose (repressing) or galactose (inducing) as the carbon source at 25C (permissive temperature) or 37C (non-permissive temperature).
(B) RNA blot analysis of SNR13. RNA was extracted from SEN1 or sen1-1 cells transformed with vector or pGSen1Myc. Cells were grown at 25C in raffinose,
expression was induced for 3 hr with 2% galactose or repressed with 2% glucose, and cells were shifted to a non-permissive temperature for 30 min. 20 mg RNA
was separated on a 1% agarose gel, and the RNA blot was probed against SNR13.
(Ci) Sequestration model. Sen1-interacting proteins are titrated away from other cellular functions (function A).
(Cii) Excess activity model. Cells with elevated Sen1 die because transcription termination occurs prematurely. Transcription termination mutants tolerate
elevated Sen1 levels by shifting the termination window back closer to the wild-type termination site.
(D) Serial 5-fold dilutions of several termination factor mutants transformed with vector or pGSen1Myc.
(E) Summary of phenotypes associated with Sen1 high copy expression in various termination mutants. +, yes; , no; NA, non-applicable.
(F) Immunoblot of samples taken from Pcf11-hemagglutinin (HA) wild-type cells transformed with vector or pGSen1Myc and induced for the indicated times with
2% galactose.
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Figure 5. Sen1 High Copy Expression Suppresses Termination Defects in APT Mutants
(A) Serial 5-fold dilutions of wild-type, ref2D, or pta1-1 cells transformedwith vector, pGSen1Myc, or two catalytically inactive point mutants of Sen1 in theWalker
A and B motifs (pGSM-K1363A and pGSM-D1590A).
(B) Immunoblot analysis of whole-cell extracts from cells induced with 2% galactose to express the indicated constructs. Because of different growth rates, the
induction time was varied for the wild-type-ref2D (6 hr) and the wild-type-pta1-1 (13 hr) pair.
(C) RNA blot analysis of SNR33 in REF2 or ref2D cells. 20 mg RNA was separated on a 1% agarose gel and normalized to the SNR33::YCR015c/SNR33 signal in
the ref2D vector samples.
(D) RNA blot analysis of SNR33 in PTA1 or pta1-1 cells, performed as in (C).Nonetheless, sensitivity to pGAL1-induced Sen1 expression on
galactose persists. Second, with other CFI, NNS, and CPF mu-
tants, higher-level Sen1 expression is toxic (Figures 4D and 4E
andS4D–S4G), and low-level Sen1 fails to suppress temperature
sensitivity.
Strikingly, several mutants in the CPF-associated APT com-
plex withstand galactose-induced Sen1 expression (ref2D,
pta1-1, ssu72-2, or swd2D [at 30C]; Figure S4G). Although
APT is critical for NNS termination, different mutations show
varying substrate specificity, possibly explaining why glc7 and
syc1mutants are still sensitive to Sen1 induction. Also tolerating
Sen1 expression was the CPF subunit mpe1-1 (Figure S4F),
which shows some NNS transcription termination defects
(M. Kim, personal communication). We excluded the trivial pos-
sibility that induction of pGSen1Myc altered the expression of
other termination factors by observing Nrd1 and Pcf11 levels
(Figure 4F). Over 24 hr induction of pGSen1Myc, neither Pcf11
nor Nrd1 steady-state levels change. Importantly, the overall
levels of Sen1 remain low, arguing that induction of Sen1-Mycis countered by lowering overall Sen1 expression. Similarly, we
rejected the possibility that Sen1-Myc expression is impaired
in two APT mutants that tolerate pGSen1Myc induction.
Although the slow mutant growth required longer induction
times, after 6 and 13 hr, respectively, Sen1 expression was equal
in wild-type and ref2D or pta1-1 mutants (Figure 5B). Therefore,
from this candidate approach, we conclude that Sen1 overex-
pression toxicity is specifically suppressed by mutations in
APT. In light of our two models, these data support the notion
that Sen1 overexpression can be toxic because of increased
transcription termination activity, which can be offset in cells
with decreased APT (Figure 4Cii).
To provide direct evidence for this hypothesis, we tested
whether Sen1 plasmid expression can suppress the accumula-
tion of read-throughSNR33::YCR015CRNA in APTmutants (Fig-
ures 5C and 5D). When pGSen1Myc is induced in either ref2D or
pta1-1 cells, readthrough transcription is suppressed by 60%.
Suppression requires Sen1 activity because point mutants in
helicase domain I (K1363A in the Walker A motif, essential forMolecular Cell 70, 312–326, April 19, 2018 319
NTP binding) or helicase domain II (D1590A in theWalker Bmotif,
essential for Mg2+binding) fail to alleviate the ref2D and pta1-1
termination defects (Figures 5C and 5D). Both mutant proteins
are dominant-negative, as can be seen by accumulation of read-
through transcripts in the wild-type. Furthermore, cells continu-
ally expressing these catalytically dead proteins die even when
APT is mutated (Figure 5A), likely explaining their lower steady-
state levels observed by immunoblot (Figure 5B).
Sen1 Increases Termination Efficiency
A further prediction from the excess activity model is that
galactose-induced Sen1 expression in wild-type cells should
lead to premature termination. To identify transcripts that
were affected by Sen1-Myc expression genome-wide, we em-
ployed native elongating transcript sequencing (NET-seq)
(Churchman and Weissman, 2012). Because NET-seq maps
nascent transcripts, its readout is independent of transcript sta-
bility and can therefore detect changes in stable and unstable
ncRNA that require Sen1 for termination. We isolated duplicate
samples for NET-seq in pGSen1Myc- or vector-transformed
cells after 3 hr of induction, where substantial Sen1 expression
was visible in the NET-seq strain but cells are still viable (Fig-
ures S5Ai–S5Aiii).
Comparison of total NET-seq reads within transcription units
reveals that this short Sen1 induction leads to a marked reduc-
tion of Pol II-associated transcripts at cryptic unstable tran-
scripts (CUTs), stable unannotated transcripts (SUTs) (1.5- to
2-fold), and, to a lesser extent, at coding genes (Figure 6A).
Individual snapshots of YER145c, CUT116, and SUT803 exem-
plify these changes (Figure 6B). This decrease in nascent tran-
scription could indicate that Sen1-overexpressing cells die
because of an overall reduction in steady-state levels of these
RNA classes. However, RNA blots for some of the most
affected coding and several strongly affected essential genes
showed that mRNA levels remain largely unchanged even after
24 hr of Sen1 induction (e.g., Ssu72; Figure S5B). Thus,
although Sen1 expression affects nascent RNA production,
mRNA steady-state levels may be less affected because of
‘‘buffering’’ of RNA degradation, which can obscure changes
in transcription rates (Sun et al., 2013). This result importantly
suggests that reduced mRNA levels are unlikely to cause
Sen1 toxicity.
Given the fluctuations in Sen1 levels over the cell cycle, we
asked whether genes whose expression changes during the
cell cycle correlate with genes affected by Sen1 overexpression.
Therefore, NET-seq was performed on asynchronous, G1- and
PM-arrested cells. Surprisingly, mean NET-seq signals are
reduced almost 2-fold in G1-arrested cells compared with asyn-
chronous or mitosis-arrested cells (Figures 6C and S5Ci–S5Ciii).
In fact, many transcripts reduced in G1 are also reduced by Sen1
overexpression, with essential and NNS-terminated genes being
significantly overrepresented (Figure 6D). However, RNA blot
analysis of RNA isolated from G1 arrested cells overexpressing
Sen1 again failed to show effects on the steady-state level of
several essential or NNS attenuated genes (data not shown).
These results indicate that increased Sen1 levels during S/G2
do not lead to an overall reduction in nascent transcripts or
mRNA levels.320 Molecular Cell 70, 312–326, April 19, 2018To deepen our analysis, we analyzed the distribution of NET-
seq reads across genes to see how Sen1 overexpression affects
transcriptional elongation and termination. Aggregate plots of
reads along transcription units, normalized to Pol II levels, allow
comparison of profile changes between different samples. At
CUTs, which are terminated by the NNS pathway, Sen1 overex-
pression reduced transcribing Pol II around the 30 end of the tran-
scription unit (Figure 7Aii). This result suggests that NNS termina-
tion becomesmore efficient with increased Sen1, supporting our
conclusion that Sen1 can be the limiting factor in this pathway
(Figures 4 and S4). Heatmaps of normalized Pol II density for in-
dividual CUTs (Figure 7B) show both a reduction of overall Pol II
density and a specific reduction at CUT 30 ends when Sen1 is
plasmid-expressed. In contrast, aggregate plots and heatmaps
of SUTs show a more homogeneous picture (Figures S6A and
S6B). In agreement with the total read analysis, CUTs and
SUTs in G1-arrested cells show an overall Pol II signal reduction
but no distribution changes compared with asynchronous or
mitosis-arrested cells (Figures 7B and S6B).
Finally, aggregate profiles of coding genes differ markedly
between samples (Figure 7C). First, within the gene body,
pGSen1Myc cells accumulate more Pol II in 30 regions upstream
of the PAS (Figure 7Cii) and relatively fewer signals around the
TSS (Figure 7Ci). A moving average analysis that identifies pause
sites in individual genes shows that pGSen1Myc samples are
more likely to pause further downstream within the gene body
(Figure 7Di). Half of the pause positions in both vector and
pGSen1Myc cells carry the motif GGTG (with T being the 30 end
of theRNA; Figure 7Dii). Pol II pausing canoccur transiently during
transcriptionor indicate aPol IImolecule in theprocessof termina-
tion (Hyman and Moore, 1993; Larson et al., 2011; Park et al.,
2004). To testwhether pausingwas associatedwithNNS termina-
tion, we examined RNA outside of the Pol II footprint for Nrd1 and
Nab3motifs.However,motif searchandmotif enrichment tools fail
to identify Nrd1 or Nab3motifs within 40 nt upstream of the pause
site (Figure S7C; Bailey et al., 2009; Carroll et al., 2004, 2007;
Creamer et al., 2011). Thus, under our experimental conditions,
Pol II has a propensity to pause at the sequence GGTG, with no
correlation to Nrd1-Nab3 sites further upstream.
The second effect of pGSen1Myc expression apparent in the
coding gene aggregate analysis is a drop in Pol II density after
the PAS (Figure 7Cii), suggestive of globally increased termina-
tion efficiency. To test the termination efficiency of individual
genes, a termination ratio was calculated as the ratio of reads
50–100 nt upstream divided by 100–50 nt downstream of the
PAS. Genes with overlapping transcription units 100 nt down-
stream of the PAS on the same strand were excluded from this
analysis. Sen1 overexpression clearly increases termination effi-
ciency (average termination coefficient = 2.545 compared with
Vector = 1.935). Individual traces of highly expressed genes,
like small nucleolar RNAs (snoRNAs) (NNS pathway) and ribo-
somal genes (poly(A) pathway and failsafe), exemplify increased
termination efficiency (Figure 7E).
Similar to Sen1-overexpressing cells, asynchronous or noco-
dazole-arrested cells have significantly higher termination coef-
ficients than G1-arrested cells (Figure 7F). Thus, the higher levels
of Sen1 in G2/M (asynchronous and mitosis-arrested cells) may
induce more efficient termination.
AB
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Figure 6. Summary of NET-Seq Results
Shown is a NETseq analysis of cells that were asynchronous, aF- or nocodazole-arrested, or induced with 2% galactose for 3 hr to express vector or
pGSen1Myc (Sen1).
(A) NET-seq values in reads per million (RPM) of two biological repeats for coding mRNA (gray, rep1 n = 6554, rep2 n = 6601), CUTs (blue, n = 922 and 925), and
SUTs (red, n = 835 and 843) in Sen1 or vector, represented as scatterplots. Right: cumulative distribution of the fold decrease in expression for coding genes,
CUTs, and SUTs after Sen1 induction.
(B) Genome browser view (igv; http://software.broadinstitute.org/software/igv/) for individual examples depicting lower Pol II reads in Sen1 samples: YER145c,
CUT116, and SUT803 (based on rep1).
(C) RPM values for coding genes (rep1 n = 6,539, rep2,3 n = 6,620), CUTs (n = 924), and SUTs (rep1 n = 834, rep2,3 n = 845) in G1-arrested versus asynchronous
cells, depicted as scatterplot.
(D) Scatterplots of fold changes comparing Sen1/vector with G1/asynchronous. Shown are coding genes (gray), CUTs (blue), and SUTs (red). Among coding
genes that are lower-expressed in G1 and Sen1 cells, essential genes (p = 2.23 1016) and NNS-terminated genes (p = 0.043, Fisher’s exact test) are significantly
overrepresented (based on rep1).
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Figure 7. Sen1 Affects Pol II Pausing and Termination Position
(A) Aggregate plot of all CUTswith a reads per kilobase of transcript permillionmapped reads (RPKM) > 10 (n = 925) anchored at the transcription start site (TSS, i)
or the annotated transcription end site (TES, ii). The shadow denotes a 95% confidence interval.
(B) Heatmap of NET-seq reads (RPM) for all CUTs in vector, Sen1 (pGSen1Myc), asynchronous, and G1-arrested cells.
(C) Aggregate plot of all coding genes with an RPKM > 10 and more than 1,000 nt (n = 2792), anchored at the TSS (i) or the poly(A) site (ii); vector (black),
Sen1 (green).
(Di) Ratio of Pol II pause intensity on gene bodies compared with promoter-proximal 300 bp in vector and Sen1 cells. Also see STAR Methods.
(legend continued on next page)
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In summary, NET-seq analysis shows that Sen1 overex-
pression distorts the transcription levels of CUTs and SUTs
and increases the termination efficiency of CUTs and mRNA.
Increased termination efficiency is also observed outside of
G1, which may be correlated with higher Sen1 protein levels.
Overall, this provides a biological rationale for keeping Sen1
levels low because excess Sen1 acts to trigger inappropriate
or premature termination.
DISCUSSION
We show in this study that Sen1 protein levels are regulated
through the cell cycle. Ubiquitin-proteasome system-mediated
degradation decreases protein levels 3- to 10-fold in G1 relative
to other cell cycle stages (Figures 1, 2, and 3). Limiting Sen1
levels appears to be essential to the cell because manipulation
of this regulation through overexpression or deletion of Sen1
degradation sequences results in greatly reduced cell viability.
Notably, increased levels of Sen1 have direct consequences for
general Pol II occupancy and termination efficiency/position, as
shown by NET-seq (Figures 6 and 7) and RNA steady
state analysis (Figure 1E). Genetic experiments indicate that
Sen1 toxicity results from excess termination activity (Figures
4 and 5).
Sen1, Nrd1, and Nab3 are required for termination of many
common ncRNA or attenuated mRNA transcripts, genetically
justifying the model of an NNS complex. Biochemical studies
suggest that the whole NNS termination complex includes
Pol II, cap binding complex, Rnt1 (RNase III), the exosome,
and the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex (Vasil-
jeva and Buratowski, 2006). However, average cellular Sen1
levels are notably lower than those of Nrd1 andNab3, suggesting
that Sen1 could be rate-limiting in the NNS pathway. Although
they do not co-purify with NNS, NNS-mediated termination
also requires Pcf11 and APT, both components of the CPF/CF
mRNA termination complex. Importantly, Sen1 has been shown
to terminate Pol II in vitro without additional factors (Porrua and
Libri, 2013). Therefore, it remains unclear whether all of these
components act during every NNS termination event or whether
different subsets of factors can be combined opportunistically to
carry out the mechanistic steps needed to ensure efficient Pol II
termination.
We sought to determine whether the abundance of Sen1 reg-
ulates NNS efficiency or might instead affect NNS-independent
functions of Sen1. Our data support both possibilities. NNS
termination is more efficient when Sen1 is more abundant; over-
all transcription at NNS-terminated CUTs is strongly affected,
and a subset of mutants that reduce NNS termination sup-
presses Sen1 toxicity. On the other hand, 30% of mRNA-encod-
ing genes are terminated more than 2-fold more efficiently when(Dii) 15 nt up and downstream of non-overlapping pause sites were searched for
(MEME) (Bailey et al., 2009). The identified motif occurred in both samples (vector
sites, p = 2.7 3 10672).
(E) Individual gene examples from vector and Sen1 samples showing SNR33, SN
(F) Boxplot for the termination ratio of the indicated samples. The termination ratio
nt downstream of the TES site. 5,702 coding genes that show no overlap with othe
end were included in the analysis. The p values represent Student’s t test.Sen1 concentration is high. These do not contain known Nrd1/
Nab3 binding sites, nor do they belong to a particular function
or pathway (gene ontology [GO] analysis). Similarly, genes that
show increased occurrence of pause sites in their body do not
classify into any GO term. Consequently, the lethality of
increased Sen1 levels cannot be definitively connected to any
particular RNA but may result from cumulative effects on many
essential mRNAs as well as the overall reduction in ncRNAs (Fig-
ures 6D and 7D).
For both Sen1 (NNS)- and Rat1 (PAS)-mediated termination
mechanisms, pausing of Pol II can promote termination, presum-
ably by providing time for the ‘‘displacing’’ enzyme to track along
the RNA and catch the elongation complex (Mischo and Proud-
foot, 2013). Thus, Rpb1 mutants with slowed elongation or con-
ditions that increase Pol II pausing partially suppress the termi-
nation and growth defects of hypomorphic sen1 mutants
(Hazelbaker et al., 2013). We therefore propose that Sen1 is re-
cruited to and acts on paused Pol II. At many sites, recruitment
occurs via Nrd1/Nab3 binding to nascent RNA and the Pol II
CTD (Chinchilla et al., 2012; Conrad et al., 2000). But if RNA is
accessible, then Sen1 may also terminate Pol II paused by other
protein-DNA roadblocks, damaged DNA, or intrinsic DNA se-
quences. In view of the toxicity of Sen1 overexpression, it is
conceivable that its access to paused Pol II has to be kept in
check by regulating its activity or reducing the available amounts
of protein. This would explain why Sen1 levels have to be higher
during G2, where two sister chromatids are present and general
transcriptional activity may be higher (Figure 6). The human
Sen1 homolog Senataxin does not change in concentration
throughout the cell cycle but alters in cellular localization,
possibly also regulating its site of action in a cell cycle-depen-
dent fashion (Y€uce and West, 2013).
Finally, Sen1, but not Nrd1 and Nab3, is required to prevent
collisions between replication forks and transcribing polymer-
ases (Alzu et al., 2012). This observation further suggests that
Sen1 can act independently of NNS and could explain why
Sen1 is required to maintain genome stability; at paused Pol II,
the dwell time of RNA at the site of negatively supercoiled DNA
upstream of Pol II is higher, increasing the probability of forming
R-loops. Thus, R-loop removal may be a side effect of Sen1
termination activity.
Future studies will aim to further dissect the action of Sen1 in
different phases of the cell cycle. Moreover, given the drastic ef-
fects of Sen1 expression on Pol II chromatin occupancy, it is
conceivable that other environmental stimuli may control Sen1
abundance. NNS action is coupled to the nutritional state of cells
(Darby et al., 2012), and together with the control of Sen1 action
described in this work, opens the fascinating possibility of
adjusting transcription termination or, more generally, ncRNA
abundance to environmental cues and stimuli.motif enrichment using multiple expectation maximization for motif elicitation
: 563 of 1,077 pause sites, p = 2.13 10639; Sen1: 708 of 1,237 identified pause
R13, RPS31, and RPL8A. The RPM scale in the igv plot is indicated.
is determined by taking the ratio of reads from 100–50 nt upstream and 50–100
r transcripts 100 nt downstream of the transcript isoform-sequencing (TIF)-seq
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Antibodies
anti-Myc (9E11) House production LRI 9E11
anti-Sen1 - (raised against N-terminal stretch of Sen1) This study
anti-TBP Buratowsi and Zhou (1992)
anti-Nrd1 Steinmetz and Brow, (1998)
anti-Nab3 (2F12) Wilson et al., (1994); kind gift
from Jeff Corden
2F12
anti-Sic1 kind gift from John Diffley
Anti-FLAG M2 affinity gel Sigma-Aldrich Cat# A2220
RRID: AB10063035
Chemicals, Peptides, and Recombinant Proteins
Alpha-Factor House production LRI
3x FLAG Peptide Sigma-Aldrich Cat#F4799
Cycloheximide Sigma-Aldrich C7698
Nocodazole Sigma-Aldrich M1404
MG-132 MERCK 474790
MG-262 Stratech A8179-APE
Deposited Data
Raw data deposition at Mendeley This study Mendeley:
https://doi.org/10.17632/bsrvhwgs5j.1
Raw Sequencing data This study GEO: GSE86419
Experimental Models: Organisms/Strains
BMA64 (MATa ura3-1 Dtrp1 ade2-1 leu2-3,112 his3-11,15) Chanfreau et al., (1998) (YF1342)
Brr5-1 (YSN399; MATa his3D200 leu2D1 ura3-52
brr5-1ade2-100 lys2-801 (amber))
Noble and Guthrie, (1996) (HY431/YF1437)
BY4741 (MATa his3D1 leu2D0 ura3D0 met15D0) Euroscarf (FY44)
BYSHM (MATa his3D1 leu2D0 ura3D0 met15D0
SEN1::His*6-TEV-Myc*18::URA3)
This study (HY202)
BYSHM Pdr5D (MATa his3D1 leu2D0 ura3D0 met15D0
SEN1::His*6-TEV-Myc*18::URA3 pdr5D::KanMX)
This study (HY270)
cdc16-123 ((W303) MATa his3-11,15 leu2-3,112 trp1-1
ura3-1 can1-100 cdc16-123)
L. Drury/J. Diffley (FY59)
cdc27-A (MATa bar1::hisG, cdc27-A, ura3, leu2, trp1,
his3, ade2 (backcrossed to W303 four times))
A. Amon (HY500/ YF2412)
Cft2-1/Ydh1D (MATa his3D1 leu2D0 ura3D0 met15D0
ydh1D::KanMX [pAK21 = ydh1-1 LEU2 CEN])
Kyburz et al., (2003) (HY403/YF2367)
Fip1-1 (LM94; MATa leu2-3,112 trp1- ura3-52 his4- fip1D::LEU2
[pIA23 = fip1-1 (L99F Q216Stop) TRP1 CEN])
Preker et al., (1995) (HY397/YF2360)
Glc7-5 (MATa his3-11,15 leu2-3,112 ura3-1 ade2-1 can1-100
ssd1-d2 glc7D::LEU2 trp1::glc7-5::TRP1)
Andrews and Stark, (2000) (HY406/YF2369)
Mpe1-1 ((W303-1B) MATa his3-11,15 leu2-3,112 trp1-1 ura3-1
ade2-1 mpe1-1 (F9S, Q268K, K337F, K354STOP))
Vo et al., (2001) (HY430/YF1982)
Nab3-11 (YPN103; (W303-1B) MATa his3-11,15 leu2-3,112
trp1-1 ura3-1 ade2- can1-100 nab3-11)
Conrad et al., (2000) (HY371/YF1471)
nrd1-101 (YJC1282; BY4741 (S288C) MATa his3D1 leu2D0
ura3D0 met15D0 nrd1-101::HA)
Jeff Corden (HY127/YF2347)
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nrd1-102 ([nrd1 (V379G)]; (S288C) MATa leu2D1
trp1D63 ura3-52 nrd1-102 [nrd1 (V379G)])
Minkyu Kim (HY479/YSB2079)
Pcf11-13 ((W303, RAD5+) MATa his3-11,15 leu2-3,112 trp1-1
ura3-1 ade2-1 can1-100 pcf11D::TRP1 [pNOPL-pcf11-13
(pcf11-13 (D68A,S69A,I170A), LEU2 CEN/ARS)])
This study (HY312)
Pcf11-2 (NA65; (W303-1B) MATa his3-11,15 leu2-3,112
trp1D ura3-1 ade2-1 pcf11-2 (E232G, D280G, C424R,
S538G, F562S, S579P))
Amrani et al., (1997) (HY366/YF1434)
Pcf11-9 (NA67; (W303-1B) MATa his3-11,15 leu2-3,112
trp1D ura3-1 ade2-1 pcf11-9 (A66D, S190P, R198G, R227G,
E354V, K435V))
Amrani et al., (1997) (HY305/YF1435)
PFS2 (MO12; (W303-1B) his3-11,15 leu2-3,112 trp1D ura3-1
ade2-1 pfs2D::TRP1 [pFL36-PFS2 = PFS2 LEU2 CEN])
Ohnacker et al., (2000) (HY407/YF2370)
Pfs2-1 (MO17; (W303-1B) his3-11,15 leu2-3,112
trp1D ura3-1 ade2-1 pfs2D::TRP1 [pFL36-pfs2-1 = pfs2-1
LEU2 CEN])
Ohnacker et al., (2000) (HY408/YF2371)
Pta1-1 (P0C8-23d; MATa leu2D1 trp1D101 ura3-52
pta1-1 ade2-1 lys2-)
O’Connor and Peebles, (1992) (HY379/YF175)
Rad2D ((S288C) MATa his3D1 leu2D0 ura3D0
met15D0 rad2D::KanMX)
Winzeler et al., (1999) (YF2230)
Ref2D ((S288C) MATa his3D1 leu2D0 ura3D0 met15D0
ref2D::KanMX)
Winzeler et al., (1999) (HY361/YF1996)
rnt1D W303) (MATa his3-11,15 leu2-3,112 Dtrp1 ura3-1
ade2-1 rnt1D::HIS3)
Chanfreau et al., (1998) (HY163/YF1343)
Shuffle strain ((BY4743; S288C) ura3D0 leu2D0
trp1D::LEU2/KanR his3D1 met15D0 sen1D::KanMX
[pRS416 +-700 Sen1])
This study (HY459/YSB3181)
Srs2D (BY4741 (S288C) MATa his3D1 leu2D0 ura3D0
met15D0 srs2D::KanMX)
Winzeler et al., (1999) YF2355
Ssu72-2 (MATa ura3-52 leu2-3,112 his3D200 ssu72-2 (R129A)) Pappas and Hampsey (2000) (HY378/YF1374)
Swd2D pRS414 D2 (MATa ura3D0 leu2D0 his3D1 met15D0
swd2D::KanMX [pRS414 +-700 Sen1 D2])
This study (HY446)
Syc1D ((S288C) MATa his3D1 leu2D0 ura3D0 met15D0
syc1D::KanMX)
Winzeler et al., (1999) (HY365/ YF2354)
W303 RAD5+ ((W303) MATa his3-11,15 leu2-3,112 trp1-1
ura3-1 ade2-1 can1-100)
Andres Aguilera (HY307/YF2329)
W303-1A (MATa his3-11,15 leu2-3,112 trp1-1 ura3-52 can1-100) Andres Aguilera (FY1)
W303bar1D ((W303) MATa his3-11,15 leu2-3,112 trp1-1
ura3-52 ade2-1 can1-100 bar1::HYG)
Mischo et al., (2011) (HY115/YF2348)
WF1ASHM (MATa leu2-3,112 trp1-1 ura3-1
SEN1::His6::TEV::Myc9::TRP1)
This study (HY185)
WF1ASHM Pds1DbD (WF1ASHM with p258 (Pds1Ddb) integrated.) This study (HY509)
WF1B (Mata ura3-1 leu2-3,112 trp1-1 his3-11,15 can1-100 sen1-1) Mischo et al., (2011) (HY71/YF2349)
WF1D (MATa ade2 his3-11,15 leu2-3,112 trp1-1 ura3 sen1-1) Mischo et al., (2011) (HY73)
YTH1 (YT2; MATa his3- leu2- trp1D ura3- ade2- yth1D::TRP1
[YCplac11-YTH1 = YTH1 LEU2 CEN])
Tacahashi et al., (2003) (HY400/YF2364)
Yth1 DC2 (YT5; MATa his3- leu2- trp1D ura3- ade2-
yth1D::TRP1 [YCplac11-yth1DC2 = yth1DC2 (amino acids
1-147 present) LEU2 CEN])
Tacahashi et al., (2003) (HY402/YF2366)
Oligonucleotides
sCR1 up (GGCTGTAATGGCTTTCTGGTG) This study N/A
sCR1 dw (CACAATGTGCGAGTAAATCCTG) This study N/A
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hm331 Sen1 Pst1 30 6369 (CATCATCTGCAGCTCGAAGAACCAC
CGGATAAAAC)
This study N/A
SB#1309 SNR13-60 (TTATAAATGGCATCTCAAATCGTC) This study N/A
SB#1310 SNR13+124 to end (GGTCAGATAAAAGTAAAAAAA
GGTAGC)
This study N/A
hm427 SNR 13 30 SacII MboI (GTCACCGCGGGATCGGATGGT
GATAGTACTCCCTGTC)
This study N/A
SB#1319 snr33 Pro-up (CGGAACGGTACATAAGAATAGAAGAG) This study N/A
SB#1322 snR33 3UTR low +288 (TAAAGAAAACGATAAGA
ACTAACC)
This study N/A
hm527 Sen1Opt F2003A F (GGTAAGAAAAAGAACAACAAGCA
CGTGTGCGCCTCCGATGATGTTTCTTCATTCC)
This study N/A
hm529 Sen1Opt R302W F (CGTTGTTTCTCAATTCTGGTCTTG
GTTATTGCCAGTTTTCAAC)
This study N/A
hm510 Sopt K1363A R (CGATAATACCCAAAATAGTCTTAGTG
GCGCCAGTACCTGGTGGACCTTG)
This study N/A
hm514 Sopt D1590A R (CGGTGCATTGACAAGCTTCAGCGAT
AATAACGGTATCGAAC)
This study N/A
hm472 S D1 30 (CATTTATAATAAACAGATGCGC) This study N/A
hm492 Sopt D4 R (GGCAATAATTCTCAAGAAAGCCATG) This study N/A
hm493 Sopt D5 F 1494 (TTCGAAACTGTCTTGTTGACCAAGAC) This study N/A
hm480 D4 R 1374 IIA (GGCTATTATACGCAGGAACGCC) This study N/A
hm477 S D5 F 1494 (TTTGAAACAGTACTGTTGACTAAAAC) This study N/A
hm539 F2003A introd Pml1 (GGTAAAAAGAAAAATAACAAACA
CGTGTGTGCTTCGGATGATGTTAGTTTCATACC)
This study N/A
hm473 S D2 F 2067 (AATACATTTGACGTTGAGGGTAGAC) This study N/A
hm550 ssu72 50 53+ (CAACAATCGTTCAATGGAATCGC) This study N/A
hm551 ssu72 30 311 (CTTTCTTGCCATTTTTCAGGTGC) This study N/A
SB#1623 Nrd1 ORF0-down (CTTATGTTCAAGTTTAAAGGAGGAC) This study N/A
SB#1640 Nrd1 1aa-up(+1) (ATGCAGCAGGACGACGATTTTCAA) This study N/A
SB#3861 SEN1 - Dbox1mut R (AGTCGCCACAGCTGCCAACAAG
GCAGTTGCTGAATT)
This study N/A
SB#3856 2 SEN1 - KEN WT F (ATTAAGGAAAATGAAAGGGCAA
TGCTTTATAAGAATGATG)
This study N/A
SB#3860 3 SEN1 - Dbox1wt R (AGTCAACACAGCCCTCAACAA
GGCAGTTGCTGAATT)
This study N/A
SB#3859 4 SEN1 - KEN-AAA+Dbox2mut F (ATTGCAGCGGCCG
AAGCGGCAATGGCGTATAAGAATGATGAATTTGAA)
This study N/A
SB#3858 5 SEN1 - Dbox2mut F (ATTAAGGAAAATGAAGCGGC
AATGGCGTATAAGAATGATGAATTTGAA)
This study N/A
SB#3857 6 SEN1 - KEN-AAA F (ATTGCAGCGGCCGAAAGGGC
AATGCTTTATAAGAATGATGAATTTG)
This study N/A
Recombinant DNA (see also Table S1)
pYMHHM Genescript
pGSen1Myc Geneart
pGSM-F2003A This study
pGSM-R302W This study
pGSM-K1363A This study
pGSM-D1590A This study
pGSen1Myc-459-498D This study
pRS416 +-700 Sen1 This study
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pRS414 +-700 Sen1 This study
pRS414 +-700 Sen1 459-498D This study
pRS414 +-700 Sen1 D2 This study
pRS414 +-700 Sen1-KEN A This study
pRS414+-700 Sen1-Dbox2 A This study
pRS414+-700 Sen1-Dbox1 Dbox2 A This study
pRS414+-700 Sen1-Dbox1 KEN A This study
pRS414+-700 Sen1-KEN Dbox 2 A This study
pRS414+-700 Sen1-Dbox1 KEN Dbox 2 A This study
pRS414+-700 Sen1-D485-505 This study
P258 This study
Software and Algorithms
TopHat2 Kim et al. (2013)
HTSeq package Anders et al., (2015)
deepTools Ramı´rez et al. (2014)
FIMO Grant et al. (2011)CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Hannah
Mischo (Hannah.Mischo@path.ox.ac.uk)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strains
Strains are listed in the Key Resources Table and were derivatives of either W303 (MATa his3-11,15 leu2-3,112 Dtrp1 ura3-1 ade2-1
can1-100) or BY4741 (MATa his3D1 leu2D0 ura3D0 met15D0).
Cell growth and arrest
Cells were cultivated in YPD (10% yeast extract, 20% bacterial peptone, 2% glucose) or minimal media as indicated in the text.
Unless otherwise noted, cells were cultivated at 30C, or at 25C for temperature sensitive strains. Prior to galactose induction, cells
were grown in 2% raffinose in minimal selective media, to which 2% galactose was added for indicated times.
Elutriation
3x1010 cells were condensed from 2 L to 40mL inmedia without carbon source and sonicated for 10 s. at 30%. Cells were loaded into
the elutriation chamber and separated at 2700 to 1400 rpm.
aFactor arrest and release
Cells were grown to a density of 1.5 2.5x 107 cells/ml in minimal complete media or YPD, pH adjusted to 3.9 with HCl and cells
arrested by two additions of 5 mg/ml aF at 0 and 60 min. Arrest was confirmed by microscopic observation after 90 to 120 min.
Release from arrest was achieved by two washes with medium.
aF/HU/Nocodazole arrest
BAR1 deleted strains were arrested at 0.5 1x 107 cells/ml without acidification by addition of 0.15 mg/ml aF for 90-120 min. BAR1
carrying strains were arrested after acidification of the media to pH 3.9 with twice 5 mg/ml aF (60 and 60 min., 120 min total).
Cells were arrested at densities of 1x 107 cells in S-phase with hydroxyurea (SIGMA, H8627) added to 0.2 M or in G2/M with
15 mg/ml nocodazole (SIGMA, M1404) in DMSO for 90 min to 2hrs, as judged by eye and depending on the growth rate of the strain.
Arrest at 25C for temperature sensitive strains was usually achieved after 3-3.5 hr.
Plasmid shuffle experiment
HY459 (shuffle strain sen1D, carrying trp1::LEU2 and pRS416+-700Sen1) is transformed with centromeric plasmids pRS414,
pRS414 +-700 Sen1 and its derivatives (see Key Resources Table). Transformants are selected on –WLU plates to select for querye4 Molecular Cell 70, 312–326.e1–e7, April 19, 2018
plasmid (-W), pRS416 +-700 Sen1 wild-type plasmid (-U) and LEU (-L), to ensure that the trp1::LEU2 disruption is not popped out.
After growth for 20 hr in liquid media, cells are spotted as five-fold serial dilutions onto –WLU plates to monitor general growth and
5-FOA containing plates to shuffle out the wild-type plasmid pRS416 +-700Sen1 and leave the query plasmid as only copy.
Spotting experiments
Overnight cultures are diluted to 4x 107 cells/ml (Figures 4, 5, S3C, and S3D) or 0.5x 107 cells/ml (Figure 4A) and spotted as 3 ml spots
in 1:5 serial dilutions. Temperature sensitive strains were grown at 25 (permissive), 30 (semi-permissive) or 37C (non-permissive
temperature) as indicated in the figures.
Fluorescent activated cell sorting (FACS)
0.6x 107 cells were fixed in 70% ethanol at 20C until further processing. Ethanol was removed and RNA digested with 20 mg/ml
RNase A in 50mMTris pH 8.0 for 90min at 37C. RNase A was removed and cells resuspended in 1mg/ml Pepsin 0.5MHCl in dH2O
to digest cell walls for 30 min at 37C. Cells were pelleted and then resuspended in 50 mM Tris pH 8.0. Typically 6x 105 cells were
stained with 0.5 mM Sytox green (Molecular Probes S7020), briefly sonicated and analyzed in a FACS Calibur (BD).
METHOD DETAILS
Protein analysis
Whole cell extract analysis
NaOH lysis 7x 107 cells are pelleted, washed in water, lysed in 100 mM NaOH for 3 min. at room temperature (RT), cooled on ice for
30 s, and spun for 50 at 13000 rpm for 5min. Protein pellets are resuspended in 50 ml SDS loading dye (0.06MTris pH 6.8, 5%glycerol,
2% SDS, 4% bME, 0.0025% BPB) and ca 0.75x 107 cells loaded per lane (Kushnirov, 2000).
TCA whole cell extract
Washed cells were resuspended in 10%TCA, combinedwith an equal volume of glass beads, and broken in aMagNA-lyser (ROCHE)
at 6000 rpm for 15 s. Beads were washed with 500-1000 ml 10% TCA and spun for 5 min at 9000 rpm. Air-dried protein pellets were
resuspended in 50-120 ml TCA loading dye (1x SDS Laemmli dye, 0.4M Tris pH 11).
Cycloheximide (CHX) shutoff for plasmid expressed Sen1
pGSen1Myc transformed cells were grown in selective media with 2% raffinose to a density of 3x 107 cells/ml and then arrested with
aFactor or nocodazole. Upon arrest, tagged Sen1 expression was induced with 2% galactose for 15 min, then further transcription
was repressed with 2% glucose for 45 min, and the chase started 60 min after galactose induction by addition of 1 mg/ml cyclohex-
imide (50 mg/ml in DMSO) to the medium. 5 mL time points were spun, washed, flash frozen in liquid nitrogen and processed to
extract using TCA. Approximately 2x107 cells/lane were loaded onto a two-percentage (15 /11%)-SDS-polyacrylamide gel.
pGSen1Myc transformed cdc27-A or wild-type cells (both bar1D), were grown in selective media with 2% raffinose to a density of
0.5x 107 cells/ml at 23C and arrested with aF (0.15 mg/ml). Upon arrest cells were shifted to 37C and concomitantly pGSen1Myc
expression induced by addition of 2% galactose for 15min. Transcription was then repressed with 2% glucose while keeping cells at
37C for a further 15 min. A 6 mL aliquot of cells was taken after a total of 30 min. at 37C for time 0 and immediately 1 mg/ml CHX
added. All further time points were taken from cells maintained at 37Cas 6mL aliquots. Each aliquot was processed and analyzed as
indicated above.
CHX shutoff of endogenous Sen1
SEN1-Myc cells at 0.7x107 cells/ml were arrested with 5 mg/ml aF, and upon arrest split in half. Deletion of the general drug exporter
PDR5makes this strain sensitive to the uptake of both inhibitors (Golin et al., 2007). Both inocculeswere exposed to 1mg/ml CHX and
in addition, one received 0.57% DMSO, the other 140 mMMG-132 (MERCK) and 20 mMMG-262 (Stratech). Approximately 0.3x107
cells were loaded in each lane and separated on a 15/11% SDS-PAGE gel.
SEN1-Myc or SEN1-Myc Pds1Db1D cells were grown in raffinose to a density of 0.6x107 cells/ml, arrested with 5 mg/ml aF and
either (SEN1-Myc Pds1Db1D), washed twice with YP, resuspended to a density of 0.3x107 cells/ml in the presence of 2% galactose
and 50 mg/ml Pronase. Cells typically released and arrested in metaphase after 80min., at which point, the culture was condensed
back to 0.6x107 cells/ml and time point 0 (6 ml) was taken. 1 mg/ml CHX was added to the remaining cultures and 6 mL time points
taken at indicated time points. aF arrested SEN1-Myc cells were incubated with additional aF andmaintained in 2%galactose for 80’
before they were treated with CHX in parallel with the metaphase arrested culture.
RNA analysis
RNAwas extracted from typically 6x 108 cells/ml by addition of 400 mL AE buffer (50mMsodium acetate pH 5.0, 10mMEDTA pH 8.0),
50 ml 10%SDS and 500 ml phenol:chloroform:isoamylalcohol (PCA, 25:24:1, pH4.5) for a period of 5 min at 65C. The aqueous phase
was extracted twice with PCA and ethanol precipitated.
RNA Blot
RNA was separated on 1% agarose gels in MOPS and transferred by capillary force in 20 x SSC. Probes were generated by strand
specific PCR with primers indicated using 32Pa-dATP and hybridized in phosphate hybridization buffer at 65C (0.3 M phosphate
buffer pH 7, 7% SDS, 0.01 g/ml BSA and 1 mM EDTA pH 8.0) and probes washed from membranes with 2 x SSC (150 mM NaCl,Molecular Cell 70, 312–326.e1–e7, April 19, 2018 e5
15 mM sodium citrate), 0.1% SDS. Probes were generated by strand-specific labeling of a PCR product (primer pairs in brackets, 30
cycles) with the antisense (reverse) primer to generate a single stranded, internally labeled probe (one NTP replaced with labeled
NTP, 30 cycles): NRD1: PCR (SB1640- SB1623), labeling: SB1623. SNR13: PCR(SB1309-hm427), labeling, hm427 or SB1310.
SNR33: PCR(SB1319-1322), label with SB1322 . Sen1: BamH1 fragment out of pRS416 +-700 Sen1, label with hm331. sCR1:
PCR with (sCR1 up and down), label with sCR1 down. Ssu72: PCR: hm550, 551, labeling hm551.
NET-seq
W303 bar1D Rpb3::Flag cells were grown in minimal complete medium and harvested at a density of 5x107 cells/ml (asynchronous
sample, 1320ml) or arrested with 0.15 mg/ml aF (5x107 cells/ml for 2.5 hr) or 15 mg/ml nocodazole (3x107 cells/ml for 2 hr.). For Vector
and Sen1 samples,W303 bar1DRpb3::Flag cells were transformedwith pGSen1Myc or pYMHHM, grown in selectiveminimal media
in raffinose and induced for 3hrs with 2% galactose. Cells were harvested through filtration and frozen biomass disrupted in a mixer
mill for 15 min at 15 Hz in 5 3-min intervals.
NET-seq conditions, immunoprecipitations, isolation of nascent RNA, and library construction were carried out as previously
described (Churchman and Weissman, 2012), with the following modifications. Ligation of adapters was done directly to the 30
end of isolated nascent RNA. A random hexamer sequence was added to the linker to improve ligation efficiency and allow for
the removal of any library biases generated from the RT step as described inMayer et al. (Mayer et al., 2015). After library construction
the size distribution of the library was determined by using a 2100 Bioanalyzer (Agilent) and library concentrations were determined
by Qubit 2.0 fluorometer (Invitrogen). 30 end sequencing of all samples was carried out on an Illumina NextSeq 500 with a read length
of 75.
Sequencing data alignment
NET-seq reads were aligned as follows. The adaptor sequence (ATCTCGTATGCCGTCTTCTGCTTG) was removed from all reads
using cutadapt with the following parameters: -O 3 -m 1–length-tag ‘length = ‘. Raw fastq files were filtered using PrinSeq (http://
prinseq.sourceforge.net/) with the following parameters: -no_qual_header -min_len 7 -min_qual_mean 20 -trim_right 1 -trim_ns_right
1 -trim_qual_right 20 -trim_qual_type mean -trim_qual_window 5 -trim_qual_step 1. Random hexamer linker sequences (the first
6 nucleotides at the 50 end of the read) were removed using custom python scripts but remained associated with the read and reads
were then aligned to the SacCer3 genome obtained from the Saccharomyces Genome Database using the TopHat2 aligner with
the following parameters:–read-mismatches 3–read-gap-length 2–read-edit-dist 3–min-anchor-length 8–splice-mismatches
1–min-intron-length 50–max-intron-length 1200–max-insertion-length 3–max-deletion-length 3–num-threads 4–max-multihits
100–library-type fr-firststrand–segment-mismatches 3–no-coverage-search–segment-length 20–min-coverage-intron 50–max-
coverage-intron 100000–min-segment-intron 50–max-segment-intron 500000–b2-sensitive. To avoid any bias toward favoring
annotated regions the alignment was performed without providing a transcriptome. Reverse transcription mispriming events are
identified and removed where molecular barcode sequences correspond exactly to the genomic sequence adjacent to the aligned
read. For NET-seq only the position corresponding to the 50 end of the sequencing read (after removal of the barcode), which
corresponds to the 30 end of the nascent RNA fragment, is recorded with a custom python script using HTSeq package (Anders
et al., 2015).
Gene expression analysis
For gene expression analysis each dataset was first normalized by the number of 106 uniquely mapped reads. The reads per gene per
million mapped reads (RPM) were calculated for genes that were expressed in at least one of the samples being compared. To allow
comparison of genes that were expressed in only one sample genes with 0 reads were given a pseudo-count of 0.1. Gene expression
was then compared by plotting the log2 RPM for each sample. Annotations for coding genes were derived from Pelechano et al.
(2013) by taking the major transcript isoform for each gene. CUT and SUT annotations obtained from Xu et al. (2009). Cumulative
distribution functions for differences in gene expression were calculated by taking the log2 ratio of expression for each gene in
one sample compared to another.
Average profile analysis around the TSS and polyadenylation site ‘aggregrate plots’
NET-seq reads around the TSS and polyadenylation sites are calculated for non-overlapping genes in 1bp bins using the deepTools
program (Ramı´rez et al., 2014). Annotation for TSS and pA sites were derived from (Pelechano et al., 2013) by taking the major tran-
script isoform for each gene. The TSS and pA average profiles were calculated using non-overlapping protein coding genes with an
RPKMgreater than 10 in the empty vector NET-seq data and that are at least 500 bp long (N = 2792). TSS and 30 end profiles for CUTs
and SUTs were calculated using all annotated CUTs and SUTs from Xu et al. (Xu et al., 2009). Data for each plot are normalized as
follows. First, each NET-seq library is normalized by the number of million uniquely mapped reads. NET-seq data for each gene used
in the average profile is then normalized by summing the total number of reads for that gene and dividing by the length of the window
analyzed. Each position is then normalized by average density value for that gene, thereby equalising the contribution from lowly
and highly expressed genes. For TSS analysis this length is 1100 and for pA analysis 550. After each gene is normalized the average
profile and 95% confidence interval are calculated, using a 25 base pair sliding window, which results in average Pol II density.e6 Molecular Cell 70, 312–326.e1–e7, April 19, 2018
Pausing analysis
Pause detection in the NET-seq data was determined as described in Churchman and Weissman (2011). Briefly, the a site was
considered a pause if the Pol II density at that nucleotide was at least three standard deviations above the mean of a sliding window
of 200 bp around that position. To be considered for pause analysis a position must have at least four normalized reads when NET-
seq data are normalized by106 uniquely mapped reads. Pause sites were determined for the same subset of genes used to calculate
the average Pol II profiles. To compare the pause density of regions near the promoter versus the gene body region the sum of the
pause density in the first 300 bp downstream of the TSS (promoter region) was compared to the sumof the pause density from 300 bp
downstreamof the TSS to the pA site of that gene (body). The ratio of pause density in the gene bodywas then compared to the pause
density near the promoter.
Termination efficiency
NET-seq reads for a region ± 100bp around pA sites were quantified for all genesR 200bp long and no overlap with other transcripts
at least 100 nt of TIF-seq end on same strand. Termination ratios (100 to-50 upstream/50 to 100 downstream read count) were then
plotted as boxplot using R.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data was quantified using ImageJ or AIDA image analysis software and normalized to an internal control. Details to statistical
methods including number of replicates (n) are specified in the figure legends. Significance was calculated using Student’s t test,
Fisher’s exact test and MEME (multiple expectation maximization for motif elicitation).
DATA AND SOFTWARE AVAILABILITY
The accession number for the raw and processed NET-seq data reported in this paper is GEO: GSE86419. The raw data reported in
this paper has been deposited to Mendeley: https://doi.org/10.17632/bsrvhwgs5j.1Molecular Cell 70, 312–326.e1–e7, April 19, 2018 e7
